Gene: TES

26136
TESS|TESS-2
testin LIM domain protein
protein-coding
7q31.2
Ensembl:ENSG00000135269 MIM:606085 Vega:OTTHUMG00000023092 UniprotKB:Q9UGI8
NC_000007.14
PubMed
CD|OD|ND|AD
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.918e-2 (AD)  2.754e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CARD60.874
MECOM0.853
CNN20.851
MYOF0.838
TNFRSF10A0.837
PKN30.831
TGFBR20.831
MMRN20.822
ANXA20.822
ICAM20.82

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SLC7A4-0.559
MARCH4-0.55
LRTM2-0.544
DLK2-0.542
NEUROD6-0.542
MYADML2-0.54
SVOP-0.54
SMIM18-0.538
BCL11A-0.535
TMEM179-0.535

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of TES mRNA19933214
C4727913-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of TES mRNA16788091
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in decreased expression of TES mRNA"18648102
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of TES mRNA"25380136
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C517041(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)"(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of TES mRNA"19561079
C0326424-aminophenylarsenoxide4-aminophenylarsenoxide binds to TES protein26598702
C0326424-aminophenylarsenoxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TES protein]26598702
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of TES mRNA21420995|2906747
D000082AcetaminophenAcetaminophen affects the expression of TES mRNA17562736
D020106AcrylamideAcrylamide affects the expression of TES mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 affects the expression of TES protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of TES gene27153756
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in decreased expression of TES mRNA28522335
D001104ArbutinArbutin results in increased expression of TES mRNA17103032
C006632arsenic trioxidearsenic trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TES protein]26598702
C015001arsenitearsenite results in decreased methylation of TES promoter23974009
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of TES mRNA19770486
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of TES mRNA22228805
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TES mRNA"20018196
D004958Estradiol[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TES mRNA19619570
D004958EstradiolEstradiol results in increased expression of TES mRNA19619570|2010694
C006780bisphenol Abisphenol A affects the expression of TES mRNA21786754
C006780bisphenol Abisphenol A results in increased expression of TES mRNA25181051
D002220CarbamazepineCarbamazepine affects the expression of TES mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of TES mRNA27339419
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of TES mRNA21784091
D002392Catechin[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TES mRNA24763279
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of TES mRNA23650126
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in increased expression of TES mRNA26272509
C018021cobaltous chloridecobaltous chloride results in increased expression of TES mRNA19376846
D019327Copper SulfateCopper Sulfate results in increased expression of TES mRNA19549813
D003375CoumestrolCoumestrol results in decreased expression of TES mRNA19167446
D016572CyclosporineCyclosporine results in increased expression of TES mRNA20106945|2163298
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of TES mRNA24317228
D013759DronabinolDronabinol results in increased expression of TES mRNA18454173
D013759DronabinolJUND mutant form inhibits the reaction [Dronabinol results in increased expression of TES mRNA]18454173
D013759DronabinolTES mutant form inhibits the reaction [Dronabinol results in increased expression of CDKN1B mRNA]18454173
D013759DronabinolTES mutant form inhibits the reaction [Dronabinol results in increased expression of JUND mRNA]18454173
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of TES mRNA]27941970
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of TES mRNA17361019
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of TES mRNA21266533
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of TES protein15728792
D003999Dichloroacetic AcidDichloroacetic Acid results in decreased expression of TES mRNA28962523
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of TES mRNA27392435
D002945CisplatinCisplatin results in increased expression of TES mRNA27594783
D004041Dietary FatsDietary Fats results in increased expression of TES mRNA22609946
D004128DimethylnitrosamineDimethylnitrosamine results in increased expression of TES mRNA25380136
D004147DioxinsDioxins affects the expression of TES mRNA20463971
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in increased expression of TES mRNA"23811387
C118739entinostatentinostat results in increased expression of TES mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D004791Enzyme Inhibitors[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TES protein23301498
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of TES mRNA17555576
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of TES mRNA17942748
D0150732-Acetylaminofluorene2-Acetylaminofluorene results in increased expression of TES mRNA21784091
D005485FlutamideFlutamide results in increased expression of TES mRNA24136188
D005492Folic Acid[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TES mRNA24657277
C069837fullerene C60fullerene C60 results in decreased expression of TES mRNA19167457
C039281furanfuran results in increased expression of TES mRNA26194646
D005978GlutathioneGlutathione deficiency results in increased expression of TES mRNA20621112
C511402Grape Seed Proanthocyanidins[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TES mRNA24763279
D017313FenretinideFenretinide results in increased expression of TES mRNA28973697
C016517indole-3-carbinolindole-3-carbinol affects the expression of TES mRNA21396975
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TES mRNA25613284
D007501IronIron deficiency results in increased expression of TES mRNA20368581
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of TES mRNA27392435
C410337K 7174K 7174 results in increased expression of TES mRNA24086573
D007649KetamineKetamine results in decreased expression of TES mRNA20080153
C042720mercuric bromidemercuric bromide results in increased expression of TES mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D008628MercuryMercury results in decreased expression of TES mRNA22008530
D008727Methotrexate[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TES mRNA24657277
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of TES mRNA23458150
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of TES mRNA26272509|2800136
C004925methylmercuric chloride"[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of TES mRNA23649840
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of TES mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of TES mRNA"25554681
D009285NaphthoquinonesNaphthoquinones results in increased expression of TES mRNA23811387
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of TES mRNA25380136
C022838nickel chloridenickel chloride results in increased expression of TES mRNA17312168
C022838nickel chloridenickel chloride affects the expression of TES mRNA22110744
C029938nickel sulfatenickel sulfate results in decreased expression of TES mRNA22714537
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of TES mRNA26272509
C568608PCI 5002[PCI 5002 co-treated with Zinc] results in increased expression of TES mRNA18593933
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of TES mRNA26272509
D010795Phthalic AcidsPhthalic Acids results in increased expression of TES mRNA15728792
C006253pirinixic acidpirinixic acid results in decreased expression of TES mRNA17426115
D010936Plant ExtractsPlant Extracts results in increased expression of TES mRNA23557933
D010938Plant OilsPlant Oils results in increased expression of TES mRNA23370395
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of TES mRNA22714537
D011374ProgesteroneProgesterone results in decreased expression of TES mRNA23018184
D011441PropylthiouracilPropylthiouracil results in increased expression of TES mRNA24780913
C059514resveratrolresveratrol results in increased expression of TES mRNA25905778
D012822Silicon DioxideSilicon Dioxide results in increased expression of TES mRNA23221170
D012834SilverSilver results in increased expression of TES mRNA26014281
C016104sodium bichromatesodium bichromate results in increased expression of TES mRNA25993096
D018038Sodium SeleniteSodium Selenite results in increased expression of TES mRNA24383545
D012999SomanSoman results in increased expression of TES mRNA19281266
D013629TamoxifenTamoxifen affects the expression of TES mRNA17555576
D013749Tetrachlorodibenzodioxin[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TES mRNA19619570
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of TES mRNA19619570
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of TES mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of TES mRNA19933214
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of TES mRNA21215274
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TES mRNA25613284
D013853ThioacetamideThioacetamide results in increased expression of TES mRNA21784091|2341159
D014212TretinoinTretinoin results in increased expression of TES mRNA21934132
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of TES mRNA24935251|2627250
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of TES mRNA"26743178
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of TES mRNA25979313
D014635Valproic AcidValproic Acid results in decreased methylation of TES gene29154799
D014635Valproic AcidValproic Acid results in increased expression of TES mRNA23179753|2438349
D014635Valproic AcidValproic Acid affects the expression of TES mRNA17292431|1796380
D014638VanadatesVanadates results in increased expression of TES mRNA22714537
D014640VancomycinVancomycin results in decreased expression of TES mRNA18930951
C025643vinclozolinvinclozolin affects the expression of TES mRNA19015723
C029297vinylidene chloridevinylidene chloride results in increased expression of TES mRNA26682919
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TES mRNA"27188386
C111237vorinostatvorinostat results in increased expression of TES mRNA26272509
D015032Zinc[PCI 5002 co-treated with Zinc] results in increased expression of TES mRNA18593933

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003723RNA binding-HDA22658674  
GO:0005515protein binding-IPI21278383  
GO:0008270zinc ion binding-IDA21278383  
GO:0045296cadherin binding-HDA25468996  
GO ID GO Term Qualifier Evidence PubMed
GO:0008285negative regulation of cell proliferation-IMP11420696  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-HDA21630459  
GO:0005829cytosol-IDA-  
GO:0005886plasma membrane-IDA-  
GO:0005925focal adhesion-HDA21423176  
GO:0005925focal adhesion-IDA-  
GO:0030054cell junction-IDA-  
GO:0032991protein-containing complex-IDA21278383  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
29240768The association between the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults. (2017)Jeong JEPLoS One
20554945Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer. (2010 Jul 7)Garber JEJ Natl Cancer Inst